| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.32 | 4e-12 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.35 | 2e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-10 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.3 | 5e-10 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |